# LAMIVUDINE and ZIDOVUDINE

NDC: 43063-900
Generic name: LAMIVUDINE and ZIDOVUDINE
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20150918

FDA application: ANDA079124

## Active ingredients

- LAMIVUDINE: 150 mg/1
- ZIDOVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43063-900"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43063-900
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff62c5fc-965d-4534-a571-a4f290cb9d83